Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05249465 · ClinicalTrials.gov registry record · NA
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
A NA study of Obesity and Overweight, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 1
- Study location
NCT05249465: Completed NA study of Obesity and Overweight, sponsored by Stanford University.
NCT05249465 is a NA study of Obesity and Overweight that has completed, run by Stanford University. The registered enrollment target is 176 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05249465, a NA study of Obesity and Overweight, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
This optimization trial will examine three tracking (or "self-monitoring") strategies for weight loss -- tracking dietary intake, steps, and/or body weight -- all delivered through digital health tools. The purpose of the study is to evaluate the combination of these strategies that maximizes 6-month weight loss in the context of a standalone digital health intervention for adults with overweight or obesity. The investigators will recruit 176 total participants to the trial. Recruitment will occur through remote channels. Interested individuals will be directed to an online screening questionnaire; those who are eligible will then be invited to attend an initial remote session with study personnel to ensure interest and eligibility in the study. The weight loss intervention will last 6 months, and all participants will receive a "core" treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely. Depending on which group participants are assigned to in the study, some individuals will be asked to track their dietary intake, their steps, and/or their body weight via digital tools. All study tasks will occur remotely, thus, participants never need to come in-person for any intervention or assessment tasks. The investigators will use the Multiphase Optimization Strategy (MOST) framework to identify the most effective combination of self-monitoring strategies. The factorial design will allow the research team to determine the unique and combined impact of each self-monitoring component on weight change. The primary outcome is weight change from baseline to 6 months. The research team will also assess self-monitoring engagement over 6 months and its association with weight change. To complement the main trial, the research team will also randomize half of participants to receive an interactive orientation video, in order to assess its impact on trial retention at 6 months. Overall, the informati
Primary Outcome
change in weight from baseline to 6-month followup (in kg); assessed objectively via e-scale
Conditions Studied
Interventions
- BEHAVIORAL Core behavioral weight loss intervention
- BEHAVIORAL Self-monitoring diet
- BEHAVIORAL Self-monitoring weight
- BEHAVIORAL Self-monitoring steps
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2025-06-23 |
| Phase | NA |
What the finished NCT05249465 record still lists
NCT05249465 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Core behavioral weight loss intervention is the first listed.
NCT05249465 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05249465 about?
NCT05249465 is a clinical study titled "Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention". This optimization trial will examine three tracking (or "self-monitoring") strategies for weight loss -- tracking dietary intake, steps, and/or body weight -- all delivered through digital health tools. The purpose of the study is to evaluate the combination of these strategies that maximizes 6-mont...
What is the current status of trial NCT05249465?
This trial is currently completed. It is a NA study. The enrollment target is 176 participants. The study started on 2023-09-22. Estimated completion is 2025-06-23.
What conditions does trial NCT05249465 study?
This clinical trial studies the following conditions: Obesity, Overweight, Weight Loss, Health Behavior.
What interventions are being tested in trial NCT05249465?
The interventions under investigation include: Core behavioral weight loss intervention (BEHAVIORAL), Self-monitoring diet (BEHAVIORAL), Self-monitoring weight (BEHAVIORAL), Self-monitoring steps (BEHAVIORAL).
Who is sponsoring clinical trial NCT05249465?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05249465 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05249465's enrollment target sits among peer trials
176 348th of 1053 higher than 705 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI